Literature DB >> 31634665

Decision making of individuals with heroin addiction receiving opioid maintenance treatment compared to early abstinent users.

Julia Kriegler1, Sophia Wegener2, Francois Richter3, Norbert Scherbaum4, Matthias Brand5, Elisa Wegmann6.   

Abstract

BACKGROUND AND AIMS: Individuals with heroin addiction are prone to dysfunctional decision-making. They frequently choose the short-term rewarding option of drug intake despite experiencing long-term negative consequences. Opioid maintenance treatment (OMT) is the most common treatment of heroin addiction.
METHODS: In this study, 38 individuals in an early stage of abstinence from heroin addiction (ESA-HA individuals) at the end of inpatient detoxification treatment and 41 individuals in long-term OMT were examined. Decision-making was assessed by (I) a modified version of the Iowa Gambling Task (IGT) with drug-related stimuli focusing on decision-making under ambiguity and (II) the Game of Dice Task (GDT) assessing decision-making under objective risk.
RESULTS: OMT-individuals showed significantly better performance in the IGT than the ESA-HA-individuals. They also showed significantly less craving under exposure of drug-related pictures. In the GDT, OMT-individuals showed significantly less risky decision-making than ESA-HA-individuals.
CONCLUSION: The results suggest that patients receiving OMT show better functional decision-making and lower craving reactions. It could be assumed that the effectiveness of OMT in preventing relapse is linked to better decision-making and lower craving among these patients.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Decision making; Game of dice task; Iowa gambling task; Methadone maintenance treatment; Opioid dependence; Opioid maintenance treatment

Mesh:

Substances:

Year:  2019        PMID: 31634665     DOI: 10.1016/j.drugalcdep.2019.107593

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

1.  Common and distinct brain activity associated with risky and ambiguous decision-making.

Authors:  Ranjita Poudel; Michael C Riedel; Taylor Salo; Jessica S Flannery; Lauren D Hill-Bowen; Simon B Eickhoff; Angela R Laird; Matthew T Sutherland
Journal:  Drug Alcohol Depend       Date:  2020-02-04       Impact factor: 4.492

2.  A Randomized Study of Food Pictures-Influenced Decision-Making Under Ambiguity in Individuals With Morbid Obesity.

Authors:  Marek Lescher; Elisa Wegmann; Silke M Müller; Nora M Laskowski; Ruth Wunder; Susana Jiménez-Murcia; Gregor R Szycik; Martina de Zwaan; Astrid Müller
Journal:  Front Psychiatry       Date:  2020-09-11       Impact factor: 4.157

3.  Evaluation of Risk Behavior in Gambling Addicted and Opioid Addicted Individuals.

Authors:  Edward J Gorzelańczyk; Piotr Walecki; Monika Błaszczyszyn; Ewa Laskowska; Aleksandra Kawala-Sterniuk
Journal:  Front Neurosci       Date:  2021-01-07       Impact factor: 4.677

4.  Decision making under ambiguity and risk in adolescent-onset schizophrenia.

Authors:  Dandan Li; Fengyan Zhang; Lu Wang; Yifan Zhang; Tingting Yang; Kai Wang; Chunyan Zhu
Journal:  BMC Psychiatry       Date:  2021-05-04       Impact factor: 3.630

Review 5.  Turning data into better mental health: Past, present, and future.

Authors:  Nidal Moukaddam; Akane Sano; Ramiro Salas; Zakia Hammal; Ashutosh Sabharwal
Journal:  Front Digit Health       Date:  2022-08-17

6.  Effects of Psychopathy on Neurocognitive Domains of Impulsivity in Abstinent Opiate and Stimulant Users.

Authors:  Elena Psederska; Nicholas D Thomson; Kiril Bozgunov; Dimitar Nedelchev; Georgi Vasilev; Jasmin Vassileva
Journal:  Front Psychiatry       Date:  2021-06-09       Impact factor: 4.157

7.  Social-networks-related stimuli interferes decision making under ambiguity: Interactions with cue-induced craving and problematic social-networks use.

Authors:  Elisa Wegmann; Silke M Müller; Patrick Trotzke; Matthias Brand
Journal:  J Behav Addict       Date:  2021-07-05       Impact factor: 6.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.